Literature DB >> 11313745

A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region.

B E Baysal1, J E Willett-Brozick, P E Taschner, J G Dauwerse, P Devilee, B Devlin.   

Abstract

Chromosomal region 11q22-q23 is a frequent target for deletion during the development of many solid tumour types, including breast, ovary, cervix, stomach, bladder carcinomas and melanoma. One of the most commonly deleted subregions contains the SDHD gene, which encodes the small subunit of cytochrome b (cybS) in mitochondrial complex II (succinate-ubiquinone oxidoreductase). Germline mutations in SDHD cause hereditary paraganglioma type 1 (PGL1), and suggest a tumour suppressor role for cybS. We present a high-resolution physical map spanning SDHD, covered by 19 YACs and 20 BACs. An approximate 1.1-Mb gene-rich region around SDHD is spanned by a complete BAC contig. Twenty-six new STSs are developed from the BAC clone ends. In addition to the discovery and characterisation of 15 new simple tandem repeat polymorphisms, we provide integrated positional information for 33 ESTs and known genes, including KIAA1391, POU2AF1 (OBF1), PPP2R1B, CRYAB, HSPB2, DLAT, IL-18, PTPS, KIAA0781 and KAIA4591, which is mapped by NotI site cloning. We describe full-length transcript sequence for PPP2R1B, encoding the protein phosphatase 2A regulatory subunit A beta isoform. We also discover a processed pseudogene for USA-CYP, a cyclophilin associated with U4/U6 snRPNs, and a novel gene, DDP2, encoding a mitochondrial protein similar to the X-linked deafness-dystonia protein, which is juxtaposed 5'-to-5' to SDHD. This map will help assess this gene-rich region in PGL and in other common tumours.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313745     DOI: 10.1038/sj.ejhg.5200585

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  12 in total

Review 1.  Protein phosphatase 2A: a target for anticancer therapy.

Authors:  Danilo Perrotti; Paolo Neviani
Journal:  Lancet Oncol       Date:  2013-05       Impact factor: 41.316

2.  Functional coupling of transcription factor HiNF-P and histone H4 gene expression during pre- and post-natal mouse development.

Authors:  Li-Jun Liu; Ronglin Xie; Sadiq Hussain; Jane B Lian; Jaime Rivera-Perez; Stephen N Jones; Janet L Stein; Gary S Stein; Andre J van Wijnen
Journal:  Gene       Date:  2011-05-13       Impact factor: 3.688

3.  Promoter methylation of heat shock protein B2 in human esophageal squamous cell carcinoma.

Authors:  Xiaofei Chang; Keishi Yamashita; David Sidransky; Myoung Sook Kim
Journal:  Int J Oncol       Date:  2011-01-21       Impact factor: 5.650

4.  Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.

Authors:  B E Baysal; J E Willett-Brozick; E C Lawrence; C M Drovdlic; S A Savul; D R McLeod; H A Yee; D E Brackmann; W H Slattery; E N Myers; R E Ferrell; W S Rubinstein
Journal:  J Med Genet       Date:  2002-03       Impact factor: 6.318

5.  The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles.

Authors:  Ronglin Xie; Ricardo Medina; Ying Zhang; Sadiq Hussain; Jennifer Colby; Prachi Ghule; Sakthi Sundararajan; Marilyn Keeler; Li-Jun Liu; Margaretha van der Deen; Partha Mitra; Jane B Lian; Jaime A Rivera-Perez; Stephen N Jones; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-09       Impact factor: 11.205

Review 6.  Breast Cancer Genomics: Primary and Most Common Metastases.

Authors:  Caroline Bennett; Caleb Carroll; Cooper Wright; Barbara Awad; Jeong Mi Park; Meagan Farmer; Elizabeth Bryce Brown; Alexis Heatherly; Stefanie Woodard
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

7.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

Authors:  A P Gimenez-Roqueplo; J Favier; P Rustin; J J Mourad; P F Plouin; P Corvol; A Rötig; X Jeunemaitre
Journal:  Am J Hum Genet       Date:  2001-10-16       Impact factor: 11.025

Review 8.  All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.

Authors:  Jaya Sangodkar; Caroline C Farrington; Kimberly McClinch; Matthew D Galsky; David B Kastrinsky; Goutham Narla
Journal:  FEBS J       Date:  2015-11-14       Impact factor: 5.542

9.  The tumor suppressor PP2A Abeta regulates the RalA GTPase.

Authors:  Anna A Sablina; Wen Chen; Jason D Arroyo; Laura Corral; Melissa Hector; Sara E Bulmer; James A DeCaprio; William C Hahn
Journal:  Cell       Date:  2007-06-01       Impact factor: 41.582

10.  Phosphatases: the new brakes for cancer development?

Authors:  Qingxiu Zhang; Francois X Claret
Journal:  Enzyme Res       Date:  2011-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.